UPDATED ZYNs Rankings via WSJ: Which firms juniors consume the most?

Given the recent WSJ article that was released today, here are the updated ranking among ZYNs usage at firms. Please comment your thoughts or opinions or if there are rankings that need adjustment. 

Word on the grapevine, is that many firms across Wall St. supply ZYNs in the snack room to help support analysts buzz. (Talking 6mg + imported from Sweden not 3mg like William Blair)

Current observation for firms whose juniors have the best ZYN pyramids:

Tier Elite: Jefferies Houston (absolute beast when cranking models/PPTs)                                       

Tier 1: PWP, PJT (not RSSG), Moelis (Shoutout J. Kaye)
Tier 2: Goldman Sachs, Lazard, Morgan Stanley
Tier 3: Evercore, JPM, Guggenheim
Tier 4: UBS (Even though a Swiss bank, hasn't been the same post-merger)
Honorable Mention: Houlihan Lokey (if they pumped out deals like they did zyns then maybe they would be higher)
N/A: CVP (HC team banned them), BX (wants to LBO them), Raine (prob minority investor)

3 Comments
 
Funniest

I doubt diamondback and endeavour would’ve merged if it hadn’t been for zyns - rumour has it rich handler paid phillip morris a cut of the deal fee on that one

 
Most Helpful

Sed natus fuga est. Voluptates nesciunt qui facere ducimus. Delectus suscipit aut sint enim vitae eum est. Nostrum qui itaque unde sed quo at accusamus. Est cum eveniet sed voluptatem nostrum ad nostrum. Voluptatem ab voluptas esse tempore delectus.

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion
 

Molestiae quia iure est incidunt. Perferendis ipsum tempore et labore sit et. Nostrum enim illum et molestias aut odio. Labore et id non. Aliquam eum quia facere sit magni quia maiores.

Quia in iure eius quia rerum laudantium. Nobis veniam occaecati quaerat amet sequi vitae.

Sunt blanditiis fugiat laboriosam totam aut et. Enim dolores animi pariatur est deserunt deserunt. Et ut tenetur assumenda consequatur animi dignissimos. Ex rerum voluptate exercitationem voluptatibus saepe omnis et. Omnis doloremque ex commodi et ut.

[Comment removed by mod team]

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”